Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Bio-Path Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 19.1K | 142.6K | +123.6K (+648.1%) |
| Value | $78.6K | $285.1K | +$206.5K (+262.9%) |
New holders (4)
Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 97,000 | $194.0K | 0.01% |
| HRT Financial LP | 14,085 | $28.0K | 0.00% |
| Geode Capital Management, LLC | 10,866 | $21.7K | 0.00% |
| Qube Research & Technologies Ltd | 100 | $200 | 0.00% |
Sold out (1)
Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Wells Fargo & Company | 5 | $20 |